Robert E Miller - Net Worth and Insider Trading

Robert E Miller Net Worth

The estimated net worth of Robert E Miller is at least $863 dollars as of 2024-06-07. Robert E Miller is the CFO of Sonoma Pharmaceuticals Inc and owns about 4,328 shares of Sonoma Pharmaceuticals Inc (SNOA) stock worth over $863. Details can be seen in Robert E Miller's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert E Miller has not made any transactions after 2018-03-13 and currently still holds the listed stock(s).

Transaction Summary of Robert E Miller

To

Robert E Miller Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert E Miller owns 1 companies in total, including Sonoma Pharmaceuticals Inc (SNOA) .

Click here to see the complete history of Robert E Miller’s form 4 insider trades.

Insider Ownership Summary of Robert E Miller

Ticker Comapny Transaction Date Type of Owner
SNOA Sonoma Pharmaceuticals Inc 2018-03-13 Chief Financial Officer

Robert E Miller Latest Holdings Summary

Robert E Miller currently owns a total of 1 stock. Robert E Miller owns 4,328 shares of Sonoma Pharmaceuticals Inc (SNOA) as of March 13, 2018, with a value of $863.

Latest Holdings of Robert E Miller

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNOA Sonoma Pharmaceuticals Inc 2018-03-13 4,328 0.20 863

Holding Weightings of Robert E Miller


Robert E Miller Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert E Miller has made a total of 0 transactions in Sonoma Pharmaceuticals Inc (SNOA) over the past 5 years. The most-recent trade in Sonoma Pharmaceuticals Inc is the acquisition of 267 shares on March 13, 2018, which cost Robert E Miller around $9,744.

Insider Trading History of Robert E Miller

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert E Miller Trading Performance

GuruFocus tracks the stock performance after each of Robert E Miller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E Miller is -1.75%. GuruFocus also compares Robert E Miller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E Miller within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert E Miller's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert E Miller

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.63 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.81 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert E Miller Ownership Network

Ownership Network List of Robert E Miller

No Data

Ownership Network Relation of Robert E Miller

Insider Network Chart

Robert E Miller Owned Company Details

What does Sonoma Pharmaceuticals Inc do?

Who are the key executives at Sonoma Pharmaceuticals Inc?

Robert E Miller is the Chief Financial Officer of Sonoma Pharmaceuticals Inc. Other key executives at Sonoma Pharmaceuticals Inc include Interim CFO Chad Norman White , Chief Financial Officer Jerome J Dvonch , and Chief Financial Officer Robert Grant Edwards .

Sonoma Pharmaceuticals Inc (SNOA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sonoma Pharmaceuticals Inc (SNOA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonoma Pharmaceuticals Inc (SNOA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sonoma Pharmaceuticals Inc (SNOA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sonoma Pharmaceuticals Inc Insider Transactions

No Available Data

Robert E Miller Mailing Address

Above is the net worth, insider trading, and ownership report for Robert E Miller. You might contact Robert E Miller via mailing address: 1129 N. Mcdowell Blvd., Petaluma Ca 94954.

Discussions on Robert E Miller

No discussions yet.